Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Terminated 4Not yet recruiting 2Active not recruiting 2Withdrawn 1Unknown 1Suspended 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 41Myelodysplastic Syndromes 37Leukemia 36Leukemia, Lymphocytic, Chronic, B-Cell 27Lymphoma 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Multiple Myeloma 21Lymphoma, Non-Hodgkin 20Lymphoma, Follicular 20Lymphoma, Large B-Cell, Diffuse 17Lymphoma, Mantle-Cell 16Congenital Abnormalities 16Melanoma 15Lymphoma, B-Cell, Marginal Zone 14Hodgkin Disease 14Myeloproliferative Disorders 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Burkitt Lymphoma 13Neoplasms, Plasma Cell 12Primary Myelofibrosis 11Leukemia, Myeloid, Accelerated Phase 11Neoplasm Metastasis 10Lymphoma, Large-Cell, Immunoblastic 9Leukemia, Myelomonocytic, Chronic 9Blast Crisis 9Anemia, Refractory, with Excess of Blasts 9Waldenstrom Macroglobulinemia 8Leukemia, Prolymphocytic 8Hematologic Neoplasms 8Graft vs Host Disease 8

Interventions

Cyclophosphamide 6Isotretinoin 5thymoglobulin 4fludarabine phosphate 4fludarabine 4aldesleukin 4Topotecan 4Temozolomide 4Melphalan 4Irinotecan 4Etoposide 4ribociclib 3Thiotepa 3Interleukin-2 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Busulfan 3Bone Marrow Transplantation 3Antilymphocyte Serum 3temsirolimus 2omburtamab I-131 2dinutuximab 2Vincristine 2Tretinoin 2TPI-287 2Stem Cell Transplantation 2Rituximab 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Neuroblastoma × fludarabine phosphate × Clear all
NCT04530487 2025-06-29

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 7 charts
CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Neurofibrosarcoma, Desmoplastic Small Round Cell Tumor

NCT00698009 2020-09-24

Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 2 charts
CNS

Neuroblastoma

NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

NCT00670410 2016-06-24

Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma

Columbia University

Phase 1 Terminated
15 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡